Chapter 4 Flashcards

(40 cards)

1
Q

Which of the following is NOT a core step in the NRC framework for risk assessment?

A

C. Epidemiologic correlation - The four core steps are hazard identification, dose-response assessment, exposure assessment, and risk characterization. Epidemiologic correlation is a method, not a defined step.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary goal of risk characterization in toxicology?

A

C. Integrate hazard, dose-response, and exposure data - Risk characterization synthesizes information from previous steps to describe the nature and magnitude of health risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The Delaney Clause prohibits which of the following?

A

B. Any food additive known to cause cancer - The Delaney Clause mandates a zero-tolerance policy for carcinogens in food additives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following defines a hazard in risk assessment?

A

B. Intrinsic toxic property of a chemical - Hazard refers to the inherent capability of a substance to cause harm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TEFs are used to assess risks associated with chemicals that act via which receptor?

A

B. AhR (aryl hydrocarbon receptor) - Toxic Equivalency Factors compare potency of dioxin-like compounds acting on the AhR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which in vitro assay is commonly used to evaluate mutagenicity?

A

B. Ames test - The Ames test detects mutations in Salmonella strains, often with and without liver enzyme activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the “3 Rs” in animal testing ethics?

A

A. Reduce, Replace, Refine - These principles aim to minimize animal use and suffering in testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which bioassay result may be irrelevant to human risk due to species-specific mechanisms?

A

B. Kidney tumors in male rats due to α2u-globulin binding - These tumors are specific to male rats and do not have human relevance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What statistical model is most often used in non-threshold carcinogen risk assessment?

A

A. Linear no-threshold model - This model assumes no safe dose and linear risk increase with dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which two test validation agencies are responsible for in vitro method validation?

A

B. ICCVAM and ECVAM - ICCVAM and ECVAM are U.S. and European agencies respectively for alternative testing methods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In risk assessment, MOE (Margin of Exposure) is calculated as:

A

B. NOAEL / Exposure - This ratio helps determine how far human exposure is from levels causing no observed adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the purpose of using the precautionary principle in risk characterization?

A

B. Avoid exposure when data is incomplete - It errs on the side of caution to protect health in the face of scientific uncertainty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Benchmark Dose (BMD) is typically associated with what response level?

A

C. 10% - BMD10 is commonly used as a reference dose in risk assessment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The primary limitation of epidemiologic data in risk assessment is:

A

C. Uncertain exposure levels - Often, exposures are not well quantified in human populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following chemicals can produce forestomach tumors in rodents but has limited human relevance?

A

A. BHA - The rodent forestomach does not exist in humans, limiting relevance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the usual uncertainty factor applied when deriving an RfD from a NOAEL?

A

C. 100 - A 10-fold for species differences and another 10-fold for individual variability are common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which U.S. law requires PMNs for chemical safety assessments?

A

B. TSCA - The Toxic Substances Control Act regulates new and existing chemicals.

18
Q

LADD stands for:

A

B. Lifetime average daily dose - LADD is used to assess chronic exposure risks, especially for carcinogens.

19
Q

Short-term exposure limits (STELs) are designed to:

A

C. Prevent acute toxicity - STELs limit peak exposures that may cause immediate health effects.

20
Q

A reference dose (RfD) is defined as:

A

B. NOAEL ÷ Uncertainty Factor - RfD estimates a daily human exposure likely to be without appreciable risk.

21
Q

What best describes the concept of ALARA?

A

C. Exposure reduced to the lowest level reasonably achievable - ALARA aims to minimize exposure as far as is technically and economically feasible.

22
Q

Exposure assessments typically include all EXCEPT:

A

C. Genetic expression profiles - Exposure assessments focus on routes, durations, and populations, not molecular data.

23
Q

A low MOE value typically implies:

A

B. High risk - Low MOE means the human exposure is close to or exceeds the NOAEL, suggesting risk.

24
Q

The NRC’s 1983 “Red Book” is significant because it:

A

C. Defined the four steps of risk assessment - It formalized the risk assessment framework used in regulatory science.

25
Chloracne, observed in Seveso, Italy, was primarily caused by exposure to:
C. Dioxin - The explosion released dioxins, known to cause chloracne among other effects.
26
Which factor contributes to the variability in human susceptibility to chemical exposure?
D. All of the above - Genetics, age, and circadian rhythm all influence chemical response variability.
27
In case-control studies, the primary statistical outcome is the:
C. Odds ratio - Odds ratios estimate the association between exposure and outcome in retrospective studies.
28
The primary use of benchmark dose modeling in toxicology is to:
C. Model low-dose effects more precisely than NOAELs - BMD is statistically derived and often more accurate than NOAEL for determining safe levels.
29
REACH is a regulatory framework implemented by:
D. European Union - REACH governs chemical safety and data requirements in the EU.
30
Use of omic data in risk assessment helps primarily with:
C. Understanding mechanisms of toxicity - Omics provide molecular insights into toxicant effects and pathways.
31
Risk =
A. Hazard × Exposure - Risk combines the potential for harm with the likelihood of exposure.
32
The gold standard method for evaluating chemical carcinogenicity is:
C. Animal bioassays - Long-term animal studies provide foundational carcinogenicity data.
33
What role do knockout mice serve in toxicity testing?
C. Clarify gene-specific toxicity pathways - They help researchers identify gene involvement in toxic responses.
34
The globally harmonized system (GHS) is most directly associated with:
C. Chemical classification and labeling - GHS provides standardized labeling and hazard communication rules globally.
35
The MOA (mode of action) is useful because:
B. It helps distinguish genotoxic vs. non-genotoxic carcinogens - MOA describes broad toxicological effects useful for regulatory decisions.
36
Which organ is most often affected by inhalation of high-dose titanium dioxide?
B. Lung - Inhalation of TiO2 particles overwhelms lung clearance mechanisms.
37
A reference dose derived using LOAEL typically involves an uncertainty factor of:
D. 1000 - Extra safety factors are used when NOAEL data is unavailable.
38
Which of the following defines a NOAEL?
A. Highest dose at which no adverse effect is observed - It helps in determining safe exposure levels in humans.
39
Why is saccharin-induced bladder cancer in rats not necessarily relevant to humans?
C. Mechanism involves urinary crystals not seen in humans - Species-specific bladder responses limit extrapolation.
40
Which term refers to the risk estimated to result in one additional case per million people?
D. De minimis risk - This benchmark defines an acceptable or negligible level of cancer risk.